Eastgate Biotech Corp. ETBI

Company Overview

Eastgate Biotech Corp. (OTC: ETBI) is a publicly traded company quoted on the OTC Markets platform that has historically described its activities as being focused on biotechnology, nutraceutical, and health-related product development and commercialization. Public disclosures indicate that the company has pursued opportunities tied to wellness products, alternative health technologies, and international distribution relationships, although the scope and continuity of these activities have varied over time. Available public information suggests the company has operated primarily as a small-cap development-stage enterprise rather than a large-scale commercial biotechnology company.

The company’s historical business descriptions have referenced interests in nutraceutical formulations, distribution partnerships, and biotechnology-oriented ventures targeting consumer health markets. However, publicly available operational and financial disclosures are limited compared with larger SEC-reporting issuers, and some historical descriptions of operations appear to have changed across reporting periods. Data regarding sustained revenue generation, market share, or long-term competitive advantages is inconclusive based on available public sources.